Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Guardian - UK
The Guardian - UK
Politics
Shanti Das and Jon Ungoed-Thomas

‘Orchestrated PR campaign’: how skinny jab drug firm sought to shape obesity debate

Novo Nordisk’s drug Wegovy will be available to people with a body mass index over 35 and at least one other weight-related condition.
Novo Nordisk’s drug Wegovy will be available to people with a body mass index over 35 and at least one other weight-related condition. Photograph: Vladimir Polikarpov/Alamy

During a prime-time breakfast slot on BBC Radio 4 last week, a leading obesity expert sang the praises of a blockbuster new weight-loss treatment.

The appetite-suppressing Wegovy injections were “one of the most powerful pharmaceutical tools” to date for treating obesity, Prof Jason Halford told the nation.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.